Healthcare resource utilization and costs associated with renal, bone and cardiovascular comorbidities among persons living with HIV compared to the general population in Quebec, Canada.

There is limited understanding on healthcare utilization and costs of age-related comorbidities such as cardiovascular, bone and renal disease/disorder in people living with human immunodeficiency virus, so we compared comorbidity prevalence and associated healthcare utilization and costs. Through t...

Full description

Bibliographic Details
Main Authors: Véronique Baribeau, Connie J Kim, René-Pierre Lorgeoux, Josée Brisebois, Harout Tossonian, Jean Lachaine
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0262645
_version_ 1811287325717561344
author Véronique Baribeau
Connie J Kim
René-Pierre Lorgeoux
Josée Brisebois
Harout Tossonian
Jean Lachaine
author_facet Véronique Baribeau
Connie J Kim
René-Pierre Lorgeoux
Josée Brisebois
Harout Tossonian
Jean Lachaine
author_sort Véronique Baribeau
collection DOAJ
description There is limited understanding on healthcare utilization and costs of age-related comorbidities such as cardiovascular, bone and renal disease/disorder in people living with human immunodeficiency virus, so we compared comorbidity prevalence and associated healthcare utilization and costs. Through the Quebec health insurance database, people living with human immunodeficiency virus on antiretroviral therapy for ≥6 months from January 2006 to June 2012 were categorized by their comorbidity status using International Classification of Diseases (ICD)-9 codes, and controls without human immunodeficiency virus diagnosis or antiretroviral therapy use were age and gender matched. We compared healthcare utilization and costs. A total of 3,905 people living with human immunodeficiency virus and 11,715 control individuals were included. The mean age of people living with human immunodeficiency virus was 45.3 years and 77.3% were men. Prevalence of comorbidities was higher and occurred earlier in people living with human immunodeficiency virus and increased with older age regardless of human immunodeficiency virus status. Interestingly, bone comorbidity was high (37%) and 5-fold greater in people living with human immunodeficiency virus <20 years than the controls. Polypharmacy and comorbidity scores were greater in people living with human immunodeficiency virus than controls (p<0.01), as were cardiovascular, bone and renal comorbidities (40.3%, 26.0% and 5.5%, respectively; p<0.01). People living with human immunodeficiency virus had higher healthcare utilization and costs than controls largely due to longer hospital stays and prescriptions. Mean total healthcare cost/person/year for people living with human immunodeficiency virus was CAD$6,248 and was highest for those with renal disease (CAD$19,617). Comorbidities in people living with human immunodeficiency virus are more prevalent, occur earlier and incur a higher burden on the healthcare system; earlier screening and improved preventative and management strategies may reduce the burden to people living with human immunodeficiency virus and to the healthcare system.
first_indexed 2024-04-13T03:16:39Z
format Article
id doaj.art-9a2f7d6738864e0e892abb8dc160158b
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-13T03:16:39Z
publishDate 2022-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-9a2f7d6738864e0e892abb8dc160158b2022-12-22T03:04:54ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-01177e026264510.1371/journal.pone.0262645Healthcare resource utilization and costs associated with renal, bone and cardiovascular comorbidities among persons living with HIV compared to the general population in Quebec, Canada.Véronique BaribeauConnie J KimRené-Pierre LorgeouxJosée BriseboisHarout TossonianJean LachaineThere is limited understanding on healthcare utilization and costs of age-related comorbidities such as cardiovascular, bone and renal disease/disorder in people living with human immunodeficiency virus, so we compared comorbidity prevalence and associated healthcare utilization and costs. Through the Quebec health insurance database, people living with human immunodeficiency virus on antiretroviral therapy for ≥6 months from January 2006 to June 2012 were categorized by their comorbidity status using International Classification of Diseases (ICD)-9 codes, and controls without human immunodeficiency virus diagnosis or antiretroviral therapy use were age and gender matched. We compared healthcare utilization and costs. A total of 3,905 people living with human immunodeficiency virus and 11,715 control individuals were included. The mean age of people living with human immunodeficiency virus was 45.3 years and 77.3% were men. Prevalence of comorbidities was higher and occurred earlier in people living with human immunodeficiency virus and increased with older age regardless of human immunodeficiency virus status. Interestingly, bone comorbidity was high (37%) and 5-fold greater in people living with human immunodeficiency virus <20 years than the controls. Polypharmacy and comorbidity scores were greater in people living with human immunodeficiency virus than controls (p<0.01), as were cardiovascular, bone and renal comorbidities (40.3%, 26.0% and 5.5%, respectively; p<0.01). People living with human immunodeficiency virus had higher healthcare utilization and costs than controls largely due to longer hospital stays and prescriptions. Mean total healthcare cost/person/year for people living with human immunodeficiency virus was CAD$6,248 and was highest for those with renal disease (CAD$19,617). Comorbidities in people living with human immunodeficiency virus are more prevalent, occur earlier and incur a higher burden on the healthcare system; earlier screening and improved preventative and management strategies may reduce the burden to people living with human immunodeficiency virus and to the healthcare system.https://doi.org/10.1371/journal.pone.0262645
spellingShingle Véronique Baribeau
Connie J Kim
René-Pierre Lorgeoux
Josée Brisebois
Harout Tossonian
Jean Lachaine
Healthcare resource utilization and costs associated with renal, bone and cardiovascular comorbidities among persons living with HIV compared to the general population in Quebec, Canada.
PLoS ONE
title Healthcare resource utilization and costs associated with renal, bone and cardiovascular comorbidities among persons living with HIV compared to the general population in Quebec, Canada.
title_full Healthcare resource utilization and costs associated with renal, bone and cardiovascular comorbidities among persons living with HIV compared to the general population in Quebec, Canada.
title_fullStr Healthcare resource utilization and costs associated with renal, bone and cardiovascular comorbidities among persons living with HIV compared to the general population in Quebec, Canada.
title_full_unstemmed Healthcare resource utilization and costs associated with renal, bone and cardiovascular comorbidities among persons living with HIV compared to the general population in Quebec, Canada.
title_short Healthcare resource utilization and costs associated with renal, bone and cardiovascular comorbidities among persons living with HIV compared to the general population in Quebec, Canada.
title_sort healthcare resource utilization and costs associated with renal bone and cardiovascular comorbidities among persons living with hiv compared to the general population in quebec canada
url https://doi.org/10.1371/journal.pone.0262645
work_keys_str_mv AT veroniquebaribeau healthcareresourceutilizationandcostsassociatedwithrenalboneandcardiovascularcomorbiditiesamongpersonslivingwithhivcomparedtothegeneralpopulationinquebeccanada
AT conniejkim healthcareresourceutilizationandcostsassociatedwithrenalboneandcardiovascularcomorbiditiesamongpersonslivingwithhivcomparedtothegeneralpopulationinquebeccanada
AT renepierrelorgeoux healthcareresourceutilizationandcostsassociatedwithrenalboneandcardiovascularcomorbiditiesamongpersonslivingwithhivcomparedtothegeneralpopulationinquebeccanada
AT joseebrisebois healthcareresourceutilizationandcostsassociatedwithrenalboneandcardiovascularcomorbiditiesamongpersonslivingwithhivcomparedtothegeneralpopulationinquebeccanada
AT harouttossonian healthcareresourceutilizationandcostsassociatedwithrenalboneandcardiovascularcomorbiditiesamongpersonslivingwithhivcomparedtothegeneralpopulationinquebeccanada
AT jeanlachaine healthcareresourceutilizationandcostsassociatedwithrenalboneandcardiovascularcomorbiditiesamongpersonslivingwithhivcomparedtothegeneralpopulationinquebeccanada